Michael Bison is a partner in Goodwin Procter’s nationally recognized Life Sciences and Technology Companies Practice Groups. He has over 15 years of experience representing privately held and publicly traded emerging growth companies with a strong emphasis on companies across the spectrum of the life sciences industry, including biotechnology, medical devices, diagnostics and healthcare information technology. Mr. Bison also regularly represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments, M&A and secondary stock sale transactions, as well as underwriters focused on the life sciences industry in connection with capital market and M&A transactions.

Mr. Bison often serves as outside general counsel to his clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including company formation and founder issues, venture capital and growth equity financings, public offerings, mergers and acquisitions, strategic collaborations, commercial transactions, corporate governance and general corporate matters.